Jupiter Topco LLC Takes Position in LeMaitre Vascular, Inc. $LMAT

Jupiter Topco LLC bought a new stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT) in the 2nd quarter, Holdings Channel.com reports. The fund bought 8,132 shares of the medical instruments supplier’s stock, valued at approximately $781,000.

A number of other hedge funds have also recently added to or reduced their stakes in LMAT. Illinois Municipal Retirement Fund increased its stake in shares of LeMaitre Vascular by 1.1% during the 4th quarter. Illinois Municipal Retirement Fund now owns 11,171 shares of the medical instruments supplier’s stock valued at $906,000 after acquiring an additional 123 shares during the last quarter. NewEdge Advisors LLC boosted its position in shares of LeMaitre Vascular by 4.6% in the fourth quarter. NewEdge Advisors LLC now owns 3,158 shares of the medical instruments supplier’s stock worth $256,000 after acquiring an additional 139 shares during the last quarter. Federated Hermes Inc. boosted its position in shares of LeMaitre Vascular by 0.4% in the second quarter. Federated Hermes Inc. now owns 39,659 shares of the medical instruments supplier’s stock worth $3,294,000 after acquiring an additional 155 shares during the last quarter. Pictet Asset Management Holding SA grew its holdings in LeMaitre Vascular by 5.5% in the first quarter. Pictet Asset Management Holding SA now owns 3,259 shares of the medical instruments supplier’s stock valued at $356,000 after purchasing an additional 169 shares during the period. Finally, Sound Income Strategies LLC increased its position in LeMaitre Vascular by 425.6% during the first quarter. Sound Income Strategies LLC now owns 226 shares of the medical instruments supplier’s stock worth $25,000 after purchasing an additional 183 shares during the last quarter. 84.64% of the stock is owned by institutional investors and hedge funds.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on LMAT. Weiss Ratings downgraded shares of LeMaitre Vascular from a “buy (b-)” rating to a “hold (c+)” rating in a research note on Friday, August 14th. Wells Fargo & Company cut their target price on LeMaitre Vascular from $104.00 to $94.00 and set an “equal weight” rating on the stock in a research report on Wednesday, August 5th. Citigroup reissued a “market outperform” rating on shares of LeMaitre Vascular in a research report on Tuesday, July 21st. Barrington Research lowered LeMaitre Vascular from an “outperform” rating to a “market perform” rating in a research note on Wednesday, August 5th. Finally, Wall Street Zen downgraded LeMaitre Vascular from a “buy” rating to a “hold” rating in a report on Saturday, August 1st. Three analysts have rated the stock with a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, LeMaitre Vascular presently has an average rating of “Hold” and an average target price of $110.60.

LeMaitre Vascular Price Performance

Shares of NASDAQ:LMAT opened at $80.67 on Monday. The company has a quick ratio of 13.96, a current ratio of 16.31 and a debt-to-equity ratio of 0.40. LeMaitre Vascular, Inc. has a 52-week low of $78.27 and a 52-week high of $118.01. The company has a 50 day moving average of $91.88 and a two-hundred day moving average of $99.18. The company has a market capitalization of $1.84 billion, a price-to-earnings ratio of 28.31, a price-to-earnings-growth ratio of 2.33 and a beta of 0.50.

LeMaitre Vascular (NASDAQ:LMAT) last announced its earnings results on Tuesday, August 4th. The medical instruments supplier reported $0.74 earnings per share for the quarter, missing the consensus estimate of $0.81 by ($0.07). LeMaitre Vascular had a net margin of 25.02% and a return on equity of 15.63%. The firm had revenue of $70.38 million during the quarter, compared to analysts’ expectations of $71.47 million. During the same quarter last year, the company posted $0.60 earnings per share. LeMaitre Vascular’s revenue for the quarter was up 9.6% compared to the same quarter last year. As a group, analysts forecast that LeMaitre Vascular, Inc. will post 2.89 earnings per share for the current fiscal year.

LeMaitre Vascular Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Thursday, September 3rd. Investors of record on Thursday, August 20th were paid a $0.25 dividend. The ex-dividend date was Thursday, August 20th. This represents a $1.00 annualized dividend and a dividend yield of 1.2%. LeMaitre Vascular’s payout ratio is 35.09%.

About LeMaitre Vascular

LeMaitre Vascular, Inc is a specialty medical device company focused on the development, manufacture and marketing of products for the treatment of peripheral vascular disease. Headquartered in Burlington, Massachusetts, the company’s offerings include a broad portfolio of vascular surgical instruments, grafts, patches, catheters and embolic protection devices. LeMaitre’s product lines address key areas such as arterial reconstruction, endovascular repair and vascular access, serving the needs of cardiovascular surgeons and interventional specialists.

Founded in 1983 by George D.